Abstract:RJ‐synthesized AgNPs demonstrate a significant inhibitory effect on the growth of HeLa and A549 cancer cells in a dose‐dependent manner. Inhibition of the PI3K/Akt pathway and decreased NO levels, VEGF, and MMP‐2 indicate a comprehensive impact on cancer cell behavior, angiogenesis, and metastasis. The inhibition of the VEGF/PI3K/Akt pathway and the quantitative increase of MDA (therefore ROS increase) are the basis of RJAgNP cytotoxicity. In recent years, nanotechnology has revolutionized various sectors, particularly in nanomedicine, where nanomaterials are used for diagnosis, monitoring, control, prevention, and treatment. Among these, silver nanoparticles (AgNPs) stand out due to their remarkable antimicrobial and cytotoxic properties. Traditional chemical synthesis of AgNPs poses significant environmental and health risks. This study introduces a novel, eco‐friendly synthesis method using royal jelly (RJ), a nutrient‐rich secretion from honeybees, to produce AgNPs with potent anticancer effects. Our research provides a detailed investigation into RJ‐mediated AgNPs' modulation of the VEGFa/PI3K/Akt/MMP‐2 pathway in HeLa and A549 cancer cell lines. AgNP characterization was performed by applying UV–Vis spectroscopy, dynamic light scattering (DLS), and transmission electron microscopy (TEM) in combination with selected area electron diffraction (SAED). Cell signaling system components were determined by ELISA analysis. The cells were subjected to staining with hematoxylin and eosin to visualize the treatment's effects. This study focuses on the green synthesis of AgNPs using RJ and its bioactivity against cancer cells. It provides a detailed characterization of the nanoparticles and examines their effects on cancer cells, specifically HeLa cervical cancer and A549 lung cancer cell lines. Green synthesized AgNPs demonstrate significant cytotoxic effects against HeLa and A549 cancer cell lines. The underlying molecular mechanisms contributing to their anticancer activity were elucidated. Our findings revealed a significant decrease in arginase activity upon exposure to AgNPs, accompanied by reductions in PI3K and phosphorylated and total Akt levels, indicative of pathway inhibition. Additionally, RJAgNP demonstrated a capacity to reduce nitric oxide levels and suppress angiogenesis‐related factors like VEGF and MMP‐2 and inflammation‐related factors like TNF‐α and COX‐2, thus impeding angiogenesis and metastasis. Moreover, our results shed light on the involvement of reactive oxygen intermediates (ROIs) in mediating apoptotic pathways, as evidenced by the increase in malondialdehyde (MDA) concentration and the corresponding decrease in Akt levels, ultimately promoting death in cancer cells. Our study contributes significantly to the field of nanomedicine and cancer therapy by introducing the use of green synthesis AgNPs using RJ and providing in‐depth insights into their molecular mechanisms of anticancer action. Our research findings demonstrate the anticancer potential of RJ‐AgNPs by targeting the VEGFa/PI3K/Akt/MMP‐2 pathway and modulation of ROS/RNS in cancer cells.

Inhibitory Effects of Royal Jelly and Its Functional Components on the Proliferation of MKN-28 Gastric Cancer Cells

Exploring In Vitro Potential of Royal Jelly Against Glioblastoma and Neuroblastoma: Impact on Cell Proliferation, Apoptosis, Cell Cycle, and Biomolecular Content

Dietary Compounds Galangin and Myricetin Suppress Ovarian Cancer Cell Angiogenesis

Antitumor Activity of Royal Jelly and Its Cellular Mechanisms against Ehrlich Solid Tumor in Mice

Dose-Dependent Effects of Royal Jelly on Estrogen- and Progesterone-Induced Mammary Gland Hyperplasia in Rats

Royal Jelly: Beneficial Properties and Synergistic Effects with Chemotherapeutic Drugs with Particular Emphasis in Anticancer Strategies

Royal jelly arranges apoptotic and oxidative stress pathways and reduces damage to liver tissues of rats by down-regulation of Bcl-2, GSK3 and NF-κB and up-regulation of caspase and Nrf-2 protein signalling pathways

Astragalus Extract Inhibits Proliferation but Enhances Apoptosis in Gastric Cancer.

Royal Jelly Attenuates LPS-Induced Inflammation in BV-2 Microglial Cells Through Modulating NF-κB and P38/jnk Signaling Pathways

Inhibitory Effect of RRTJ and NoniJ on Growth of Human Ovarian Cancer Cells

Royal jelly and its hormonal effects in breast cancer: a literature review

[Construction of RegIα Over-Expression Vector and Its Effect on Proliferation and Apoptosis of Gastric Cancer Cells].

Anti-inflammatory and immune-enhancing effects of enzyme-treated royal jelly

Royal Jelly and Chlorella vulgaris Mitigate Gibberellic Acid-Induced Cytogenotoxicity and Hepatotoxicity in Rats via Modulation of the PPARα/AP-1 Signaling Pathway and Suppression of Oxidative Stress and Inflammation

Oral Intake of Royal Jelly Has Protective Effects Against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial

Anti-senescence Effect and Molecular Mechanism of the Major Royal Jelly Proteins on Human Embryonic Lung Fibroblast (HFL-I) Cell Line

Royal Jelly–Mediated Silver Nanoparticles Show Promising Anticancer Effect on HeLa and A549 Cells Through Modulation of the VEGFa/PI3K/Akt/MMP‐2 Pathway

Anticancer Activity of Phloretin Against Human Gastric Cancer Cell Lines Involves Apoptosis, Cell Cycle Arrest, and Inhibition of Cell Invasion and JNK Signalling Pathway

The Inhibitory Effect and Mechanism of the Histidine-Rich Peptide rAj-HRP from Apostichopus japonicus on Human Colon Cancer HCT116 Cells

Identification of an Antitumor Effect of Demethylzeylasteral on Human Gastric Cancer Cells.

Royal Jelly Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Oxidative Stress and Regulating the Expression of Circadian Genes in Ovariectomized Rats